Results 81 to 90 of about 36,179 (151)

Drug strategies for the treatment and prevention of proliferative vitreoretinopathy: an overview of innovative treatment concepts. [PDF]

Int Ophthalmol
Luyken AK, Junge V, Schulz A, Fuchsluger TA, Schaub F.   +4 more
europepmc   +1 more source

Necrotizing soft tissue infection of the fingertips secondary to paronychia in a leukemic child: a case report and warning. [PDF]

Front Pediatr
Li N, Zhang Z, Lu Y, Wu H, Zhang Y, Cong F.   +5 more
europepmc   +1 more source

Studying clonal heterogeneity of acute myeloid leukemia under nutrient and chemotherapy stress. [PDF]

Blood Adv
Mayerhofer C, Crompton E, Mayerhofer E, Kristiansen T, Fukushima T, Keyes S, Sharda A, Li D, Da Silva C, Shrestha D, Kiem A, Feuchtinger T, Scadden DT, Miller PG.   +13 more
europepmc   +1 more source

QSPR analysis of anticancer drugs using the Euler-Sombor index and theoretical insights on its minimum value for unicyclic graphs. [PDF]

Sci Rep
Shetty S, Rakshith BR, Udupa NVS.
europepmc   +1 more source

SRSF2 mutations drive daunorubicin resistance in acute myeloid leukemia via THBS1 stabilization. [PDF]

J Exp Clin Cancer Res
Ye W, Wu X, Tang Y, Zhang Y, Du Y, Yang K, Yang Y, Gong Y.   +7 more
europepmc   +1 more source

Clinical Integration of Menin Inhibitors in AML: Evolving Data and Therapeutic Perspectives. [PDF]

Oncol Res
Chen T, Kim G, Rahimi Y, Kamdar M, Fernandez-Hernandez E, Woan K, Tam EL, Yaghmour G.   +7 more
europepmc   +1 more source

cellMCD Effectively Discovers Drug Resistance and Sensitivity Genes for Acute Myeloid Leukemia. [PDF]

Genes (Basel)
Obodo D, Nguyen NHK, Cao X, Parcha PK, Vulpe CD, Lamba JK, Pounds SB.   +6 more
europepmc   +1 more source

Mathematical modeling and statistical analysis of breast cancer drugs using M-polynomial indices for the physical properties. [PDF]

Sci Rep
Tawhari QM, Naeem M, Maqbool S, Rauf A, Oyelakin O.   +4 more
europepmc   +1 more source

Adult Acute Myeloid Leukaemia With <i>DDX3X::MLLT10</i>: A Rare Entity With Significant Unmet Clinical Needs. [PDF]

EJHaem
Ng JY, Sr A, Joshi M, Talaulikar D.
europepmc   +1 more source

Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AML. [PDF]

Blood Neoplasia
Jain J, Pugh K, Handa S, Dvorak-Kornaus KM, Zhao Q, Walter RB, Cook R, Saultz J, Swords R, Li J, Laszlo GS, Grieselhuber NR, Mims AS, Larkin KTM, Sahasrabudhe K, Blachly JS, Behbehani GK, Eisfeld AK, Long M, Srisuwananukorn A, Koenig KL, Borate U.   +21 more
europepmc   +1 more source